Terms: = Prostate cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
33 results:
1. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and rar-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
2. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
3. rarγ: The Bone of Contention for Endothelial Cells in prostate cancer Metastasis.
Bhowmick S; Bhowmick NA
Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
[TBL] [Abstract] [Full Text] [Related]
4. Retinoic Acid Receptor Activation Reduces Metastatic prostate cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract] [Full Text] [Related]
5. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience.
Boeri L; Sharma V; Kwon E; Stish BJ; Davis BJ; Karnes RJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):514-523. PubMed ID: 33268854
[TBL] [Abstract] [Full Text] [Related]
6. Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.
Petrie K; Urban-Wójciuk Z; Sbirkov Y; Graham A; Hamann A; Brown G
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1284. PubMed ID: 32881426
[TBL] [Abstract] [Full Text] [Related]
7. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
8. Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.
Eskra JN; Kuiper JW; Walden PD; Bosland MC; Özten N
Eur J Cancer Prev; 2017 Jan; 26(1):71-77. PubMed ID: 26886237
[TBL] [Abstract] [Full Text] [Related]
9. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract] [Full Text] [Related]
10. Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer.
Rogenhofer S; Ellinger J; Kahl P; Stoehr C; Hartmann A; Engehausen D; Wieland WF; Müller SC; Hofstädter F; Walter B
Anticancer Res; 2012 Aug; 32(8):3479-83. PubMed ID: 22843934
[TBL] [Abstract] [Full Text] [Related]
11. PTOV1 antagonizes MED25 in rar transcriptional activation.
Youn HS; Park UH; Kim EJ; Um SJ
Biochem Biophys Res Commun; 2011 Jan; 404(1):239-44. PubMed ID: 21110951
[TBL] [Abstract] [Full Text] [Related]
12. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract] [Full Text] [Related]
13. Partially saturated canthaxanthin purified from Aspergillus carbonarius induces apoptosis in prostrate cancer cell line.
Kumaresan N; Sanjay KR; Venkatesh KS; Kadeppagari RK; Vijayalakshmi G; Umesh-Kumar S
Appl Microbiol Biotechnol; 2008 Sep; 80(3):467-73. PubMed ID: 18542946
[TBL] [Abstract] [Full Text] [Related]
14. CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Rogers CG; Lin X; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
J Urol; 2008 Feb; 179(2):529-34; discussion 534-5. PubMed ID: 18076941
[TBL] [Abstract] [Full Text] [Related]
15. Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
Rouprêt M; Hupertan V; Catto JW; Yates DR; Rehman I; Proctor LM; Phillips J; Meuth M; Cussenot O; Hamdy FC
Int J Cancer; 2008 Feb; 122(4):952-6. PubMed ID: 17960617
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of CpG island hypermethylation at PTGS2, rar-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
[TBL] [Abstract] [Full Text] [Related]
17. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract] [Full Text] [Related]
18. Retinoic acid via raralpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
Lou YR; Miettinen S; Kagechika H; Gronemeyer H; Tuohimaa P
Biochem Biophys Res Commun; 2005 Dec; 338(4):1973-81. PubMed ID: 16289102
[TBL] [Abstract] [Full Text] [Related]
19. Retinoid-related molecule AGN193198 potently induces G2M arrest and apoptosis in bladder cancer cells.
Reitmair A; Shurland DL; Tsang KY; Chandraratna RA; Brown G
Int J Cancer; 2005 Jul; 115(6):917-23. PubMed ID: 15729717
[TBL] [Abstract] [Full Text] [Related]
20. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer.
Peehl DM; Feldman D
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):307-15. PubMed ID: 15663994
[TBL] [Abstract] [Full Text] [Related]
[Next]
